243 related articles for article (PubMed ID: 16300867)
1. Candidate peptide-vaccines induced immunity against CSFV and identified sequential neutralizing determinants in antigenic domain A of glycoprotein E2.
Dong XN; Chen YH
Vaccine; 2006 Mar; 24(11):1906-13. PubMed ID: 16300867
[TBL] [Abstract][Full Text] [Related]
2. Candidate peptide-vaccine induced potent protection against CSFV and identified a principal sequential neutralizing determinant on E2.
Dong XN; Qi Y; Ying J; Chen X; Chen YH
Vaccine; 2006 Jan; 24(4):426-34. PubMed ID: 16154668
[TBL] [Abstract][Full Text] [Related]
3. Spying the neutralizing epitopes on E2 N-terminal by candidate epitope-vaccines against classical swine fever virus.
Dong XN; Chen YH
Vaccine; 2006 May; 24(19):4029-34. PubMed ID: 16504346
[TBL] [Abstract][Full Text] [Related]
4. Candidate multi-peptide-vaccine against classical swine fever virus induced potent immunity with serological marker.
Dong XN; Chen Y; Wu Y; Chen YH
Vaccine; 2005 May; 23(28):3630-3. PubMed ID: 15882522
[TBL] [Abstract][Full Text] [Related]
5. Partial protection against classical swine fever virus elicited by dendrimeric vaccine-candidate peptides in domestic pigs.
Tarradas J; Monsó M; Muñoz M; Rosell R; Fraile L; Frías MT; Domingo M; Andreu D; Sobrino F; Ganges L
Vaccine; 2011 Jun; 29(26):4422-9. PubMed ID: 21496472
[TBL] [Abstract][Full Text] [Related]
6. A DNA vaccine expressing the E2 protein of classical swine fever virus elicits T cell responses that can prime for rapid antibody production and confer total protection upon viral challenge.
Ganges L; Barrera M; Núñez JI; Blanco I; Frias MT; Rodríguez F; Sobrino F
Vaccine; 2005 May; 23(28):3741-52. PubMed ID: 15882536
[TBL] [Abstract][Full Text] [Related]
7. Yeast expressed classical swine fever E2 subunit vaccine candidate provides complete protection against lethal challenge infection and prevents horizontal virus transmission.
Lin GJ; Deng MC; Chen ZW; Liu TY; Wu CW; Cheng CY; Chien MS; Huang C
Vaccine; 2012 Mar; 30(13):2336-41. PubMed ID: 22300723
[TBL] [Abstract][Full Text] [Related]
8. Interferon-gamma induction correlates with protection by DNA vaccine expressing E2 glycoprotein against classical swine fever virus infection in domestic pigs.
Tarradas J; Argilaguet JM; Rosell R; Nofrarías M; Crisci E; Córdoba L; Pérez-Martín E; Díaz I; Rodríguez F; Domingo M; Montoya M; Ganges L
Vet Microbiol; 2010 Apr; 142(1-2):51-8. PubMed ID: 19896784
[TBL] [Abstract][Full Text] [Related]
9. Early onset and long lasting protection in pigs provided by a classical swine fever E2-vaccine candidate produced in the milk of goats.
Barrera M; Sánchez O; Farnós O; Rodríguez MP; Domínguez P; Tait H; Frías M; Avila M; Vega E; Toledo JR
Vet Immunol Immunopathol; 2010 Jan; 133(1):25-32. PubMed ID: 19640591
[TBL] [Abstract][Full Text] [Related]
10. Oronasal vaccination with classical swine fever virus (CSFV) replicon particles with either partial or complete deletion of the E2 gene induces partial protection against lethal challenge with highly virulent CSFV.
Maurer R; Stettler P; Ruggli N; Hofmann MA; Tratschin JD
Vaccine; 2005 May; 23(25):3318-28. PubMed ID: 15837238
[TBL] [Abstract][Full Text] [Related]
11. Glycoprotein E2 of classical swine fever virus expressed by baculovirus induces the protective immune responses in rabbits.
Zhang H; Li X; Peng G; Tang C; Zhu S; Qian S; Xu J; Qian P
Vaccine; 2014 Nov; 32(49):6607-13. PubMed ID: 25446823
[TBL] [Abstract][Full Text] [Related]
12. Yeast-expressed classical swine fever virus glycoprotein E2 induces a protective immune response.
Lin GJ; Liu TY; Tseng YY; Chen ZW; You CC; Hsuan SL; Chien MS; Huang C
Vet Microbiol; 2009 Nov; 139(3-4):369-74. PubMed ID: 19625145
[TBL] [Abstract][Full Text] [Related]
13. A common neutralizing epitope on envelope glycoprotein E2 of different pestiviruses: implications for improvement of vaccines and diagnostics for classical swine fever (CSF)?
van Rijn PA
Vet Microbiol; 2007 Nov; 125(1-2):150-6. PubMed ID: 17561359
[TBL] [Abstract][Full Text] [Related]
14. Classical swine fever virus E2 glycoprotein antigen produced in adenovirally transduced PK-15 cells confers complete protection in pigs upon viral challenge.
Sánchez O; Barrera M; Rodríguez MP; Frías MT; Figueroa NE; Naranjo P; Montesino R; Farnos O; Castell S; Venereo A; Ganges L; Borroto C; Toledo JR
Vaccine; 2008 Feb; 26(7):988-97. PubMed ID: 18192093
[TBL] [Abstract][Full Text] [Related]
15. Identification of E2 with improved secretion and immunogenicity against CSFV in piglets.
Xu H; Wang Y; Han G; Fang W; He F
BMC Microbiol; 2020 Feb; 20(1):26. PubMed ID: 32019519
[TBL] [Abstract][Full Text] [Related]
16. Enhanced protective immunity to CSFV E2 subunit vaccine by using IFN-γ as immunoadjuvant in weaning piglets.
Zhang H; Wen W; Zhao Z; Wang J; Chen H; Qian P; Li X
Vaccine; 2018 Nov; 36(48):7353-7360. PubMed ID: 30366801
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of intradermally administrated E2 subunit vaccines in reducing horizontal transmission of classical swine fever virus.
Dortmans JC; Loeffen WL; Weerdmeester K; van der Poel WH; de Bruin MG
Vaccine; 2008 Feb; 26(9):1235-42. PubMed ID: 18242794
[TBL] [Abstract][Full Text] [Related]
18. Assessment of the cell-mediated immunity induced by alphavirus replicon-vectored DNA vaccines against classical swine fever in a mouse model.
Zhao HP; Sun JF; Li N; Sun Y; Xia ZH; Wang Y; Cheng D; Qi QF; Jin ML; Qiu HJ
Vet Immunol Immunopathol; 2009 May; 129(1-2):57-65. PubMed ID: 19150136
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a new chimeric marker vaccine candidate with a mutated antigenic E2-epitope.
Reimann I; Depner K; Utke K; Leifer I; Lange E; Beer M
Vet Microbiol; 2010 Apr; 142(1-2):45-50. PubMed ID: 19892497
[TBL] [Abstract][Full Text] [Related]
20. Marker vaccine strategies and candidate CSFV marker vaccines.
Dong XN; Chen YH
Vaccine; 2007 Jan; 25(2):205-30. PubMed ID: 16934915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
